Infantile Spasms—Have We Made Progress?
- 769 Downloads
Purpose of the Review
The care of children with infantile spasms is full of areas of ambiguity, despite practice parameters and randomized trials. This review is to update the current care of children with infantile spasms.
Several recent studies have generated new data to guide management including a randomized trial supporting combination therapy of hormone treatment and vigabatrin as an initial treatment for infantile spasms. Studies have suggested that we are not consistent in our recognition of hypsarrhythmia, while additional studies suggest that the presence or absence of this pattern may not have any predictive value. Additionally, the use of appropriate medications as well as an early diagnosis has the most impact on short-term outcomes.
Children with infantile spasms benefit most from early diagnosis and early treatment with appropriate standard medications such as hormonal therapy (ACTH or prednisolone) or vigabatrin.
KeywordsInfantile spasms Hypsarrhythmia ACTH Vigabatrin Epileptic spasms West syndrome
Compliance with Ethical Standards
Conflict of Interest
Sarah Aminoff Kelley declares no conflict of interest.
Kelly G. Knupp has received grants from the Colorado Department of Health, PERF, and West Pharmaceuticals, as well as research funding from Zogenix and Greenwich Pharmaceuticals (DSMB).
Human and Animal Rights and Informed Consent
All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 8.Gibbs FA, Gibbs EL. Atlas of electroencephalography. Cambridge: Mass.: Addison-Wesley Press; 1978.Google Scholar
- 12.Chiron C, Dulac O, Beaumont D, Palacios L, Pajot N, Mumford J. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol. 1991:Suppl 2:52.Google Scholar
- 15.Fong CY, Osborne JP, Edwards SW, Hemingway C, Hancock E, Johnson AL, et al. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms. Dev Med Child Neurol. 2013;55:862–7.CrossRefPubMedGoogle Scholar
- 19.Osborne JP, Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, et al. The underlying etiology of infantile spasms (West syndrome): information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification. Epilepsia. 2010;51:2168–74.CrossRefPubMedGoogle Scholar
- 24.•• Mytinger JR, Hussain SA, Islam MP, Millichap JJ, Patel AD, Ryan NR, et al. Improving the inter-rater agreement of hypsarrhythmia using a simplified EEG grading scale for children with infantile spasms. Epilepsy Res. 2015;116:93–8. This study suggests a scale to be used in clinical practice to improve inter-rater reliability of hypsarrhythmia. CrossRefPubMedGoogle Scholar
- 25.Bajammal R, Nariai H, Numis A, Rajaraman R, Sankar R, Hussain S. Ideal duration of video-EEG to confirm response to therapy in the treatment of infantile spasms. American Epilepsy Society Meeting 2017 Abstract.Google Scholar
- 26.•• Demarest ST, Shellhaas RA, Gaillard WD, Keator C, Nickels KC, Hussain SA, et al. The impact of hypsarrhythmia on infantile spasms treatment response: observational cohort study from the National Infantile Spasms Consortium. Epilepsia. 2017;58:2098–103. This study demonstrates that EEG findings at onset (absence or presence of hypsarrythmia or presence of modified hypsarrhythmia) do not predict short-term outcomes, and use of standard medications predicts short-term outcomes. CrossRefPubMedGoogle Scholar
- 31.Sundaram SK, Chugani HT, Tiwari VN, Huq AH. SCN2A mutation is associated with infantile spasms and bitemporal glucose hypometabolism. Pediatr Neurol. 2013;49:46–9.Google Scholar
- 32.Boutry-Kryza N, Labalme A, Ville D, de Bellescize J, Touraine R, Prieur F, et al. Molecular characterization of a cohort of 73 patients with infantile spasms syndrome. Eur J Med Genet. 2015;58:51–8.Google Scholar
- 33.Hussain SA, Lay J, Cheng E, Weng J, Sankar R, Baca CB. Recognition of infantile spasms is often delayed: the ASSIST study. J Pediatr 2017;190. 221:e1.Google Scholar
- 38.•• O'Callaghan FJ, Edwards SW, Alber FD, Hancock E, Johnson AL, Kennedy CR, et al. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol. 2017;16:33–42. Randomized trial demonstrating superior efficacy of combination therapy (hormonal therapy and vigabatrin) compared to monotherapy. CrossRefPubMedGoogle Scholar
- 40.Bebin M Preventing epilepsy using vigabatrin in INfants with tuberous sclerosis complex (PREVeNT trial) [online]. Available at: https://clinicaltrials.gov/ct2/show/NCT02849457?cond=Tuberous+Sclerosis&rank=8.
- 43.Mahmoud AA, Rizk TM, Mansy AA, Ali JA, Al-Tannir MA. Ineffectiveness of topiramate and levetiracetam in infantile spasms non-responsive to steroids. Open labeled randomized prospective study. Neurosciences (Riyadh). 2013;18:143–6.Google Scholar
- 44.Auvichayapat N, Tassniyom S, Treerotphon S, Auvichayapat P. Treatment of infantile spasms with sodium valproate followed by benzodiazepines. J Med Assoc Thail. 2007;90:1809–14.Google Scholar
- 56.Swann J, Le J, Frost J. Infantile spasms: ACTH dose response relationships. American Epilepsy Society Meeting 2017Abstract.Google Scholar
- 58.Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005;4:712–7.CrossRefPubMedGoogle Scholar